Venture capital funding in the life sciences sector, which includes the biotechnology and medical device industries, increased 21 percent during 2011, according to a new PricewaterhouseCooper’s  report, “Zigzagging Upward.” Venture capitalists invested a total of $7.5 billion in 785 life sciences deals during the year, topping 2010 performance despite a drop from the third to […]
This content is only available to members of the CSBJ. To gain access, you'll need to sign in or purchase Digital, Digital Partnership, Silver Membership, Print & Digital, Print, Digital and The Transcript or Digital Monthly If you're already a member, sign in here.